Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance

Gynecologic Oncology

Volumn 111, Issue 2, 2008, Pages 330-335

  Connor, Joseph P ^a   Felder, Mildred ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; DcR3; Fas ligand; Platinum resistance

Indexed keywords

CHROMIUM; DECOY RECEPTOR 3; FAS LIGAND; PLATINUM;

ADULT; AGED; APOPTOSIS; ARTICLE; ASCITES; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; ASCITES; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B;

EID: 55649123899     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.012     Document Type: Article

References (16)

1. Chen J., Zhang L., and Kim S. Quantification and detection of DcR3, a decoy receptor in TNFR family. J. Immunol. Methods 285 (2004) 63-70
2. Wan X., Zhang J., Luo H., Shi G., Kapnik E., Kim S., et al. A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169 (2002) 6813-6821
3. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., and Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274 (1999) 13733-13736
4. Ibrahim S.M., Ringel J., Schmidt C., Ringel B., Muller P., Koczan D., et al. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Pancreas 23 (2001) 72-79
5. Li H., Zhang L., Lou H., Ding I., Kim S., Wang L., et al. Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus. Am. J. Clin. Pathol. 124 (2005) 282-287
6. Shen H.W., Gao S.L., Wu Y.L., and Peng S.Y. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis. World J. Gastroenterol. 11 (2005) 5926-5930
7. Wu Y., Han B., Sheng H., Lin M., Moore P.A., Zhang J., et al. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients. Int. J. Cancer 105 (2003) 724-732
8. Abrahams V.M., Straszewski S.L., Kamsteeg M., Hanczaruk B., Schwartz P.E., Rutherford T.J., et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 63 (2003) 5573-5581
9. Gorelik E., Edwards R.P., Feng X., Marrangoni A.M., Grandis J.R., Drenning S.D., et al. IL-12 receptor-mediated upregulation of FasL in human ovarian carcinoma cells. Int. J. Cancer 112 (2004) 620-627
10. Meng Y., Kang S., and Fishman D.A. Lysophosphatidic acid stimulates fas ligand microvesicle release from ovarian cancer cells. Cancer Immunol. Immunother. 54 (2005) 807-814
11. Kaplan D., and Sieg S. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J. Virol. 72 (1998) 6279-6282
12. Kaplan D., and Smith D. Enzymatic amplification staining for flow cytometric analysis of cell surface molecules. Cytometry 40 (2000) 81-85
13. Sieg S., Huang Y., and Kaplan D. Viral regulation of CD95 expression and apoptosis in T lymphocytes. J. Immunol. 159 (1997) 1192-1199
14. Gurney A.L., Marsters S.A., Huang R.M., Pitti R.M., Mark D.T., Baldwin D.T., et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 9 (1999) 215-218
15. Pitti R.M., Marsters S.A., Lawrence D.A., Roy M., Kischkel F.C., Dowd P., et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396 (1998) 699-703
16. Simon I., Liu Y., Krall K.L., Urban N., Wolfert R.L., Kim N.W., et al. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer. Gynecol. Oncol. 106 (2007) 112-118